By Sherry Hubbard-Bednasz
You have a human condition to improve and a protocol to follow. All smooth sailing from here, right? Indeed, even the most well-planned clinical trial is dead in the water if the needed patients are not accessible or willing to participate. Yes, we’ve been saying it for some time, that the business of conducting clinical trials is becoming more complex. Believe me, in our market research world, respondent fatigue, nonresponse, and sampling snags are real issues that affect our research goals. These also apply to clinical development, granted in a far more intricate manner. Need humans? Welcome to the challenges of dealing with them.